Atossa's Rare Pediatric Disease Designation for (Z)-endoxifen in neuromuscular diseases qualifies for a future PRV upon FDA approval SEATTLE, Feb. 5, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc.
WISN 12 News on MSN
Mother charged after 12-year-old boy dies from starvation
Mother charged after 12-year-old boy dies from starvation ...
The Reporter on MSN
Police say Fond du Lac mother neglected son who died of starvation
A Fond du Lac woman faces felony child neglect charges after her 12-year-old son, who had muscular dystrophy, died of ...
A milestone in the treatment of Duchenne muscular dystrophy (DMD) passed recently with remarkably little public notice. That ...
The Missoula Police Department is seeking information from the public, about people who were seen hiking on Mount Jumbo ...
Nearly one year ago, Gus Fitz, a Granite High School senior, passed away after a lengthy battle with Duchenne muscular dystrophy.Friends and family describe him ...
A GoFundMe has been launched for Liam Cusack, an Irish American journalist who is battling Multiple Myeloma, a deadly blood ...
Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on developing new products for rare diseases, announced today that the U.S. Food and Drug Administration (FDA ...
The wine series promises to bring the finest of Napa Valley to Newport Beach in March. The event is a fundraiser to help find a cure for Duchenne muscular dystrophy.
After a series of deaths in patients taking Sarepta Therapeutics’ gene therapies, doubt has crept into investor sentiments ...
$48.7 billion for NIH, a 1% increase that helps sustain biomedical research critical to rare disease progress. The funding includes positive policy language limiting forward funding of grants and ...
Residents of Campbell Estates in Fayette County are unable to receive mail due to GPS and mapping issues, forcing them to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results